Humacyte Eulerpool News

Humacyte Stock News

Humacyte is being monitored by journalists and investors worldwide. We gather the latest Humacyte news here.

• March 19 ·

  Benzinga
  Humacyte Files Prospectus For Offering 25M Common Stock
• March 19 ·

  Benzinga
  Humacyte shares are trading lower after the company announced a $20 million offering of 25 million shares.
• March 19 ·

  Benzinga
  Humacyte Commences $20M Offering Of 25M Common Stock
• March 19 ·

  Benzinga
  Humacyte Receives $1.475M Commitment Of Symvess Acellular Tissue Engineered Vessel For Facilitation Of Hospitals In Saudi Arabia
• March 17 ·

  Benzinga
  Humacyte Submits Marketing Authorization Application In Israel For Vascular Trauma Repair Treatment ATEV; To Seek Hospital Availability Following MAA Approval
• March 10 ·

  SeekingAlpha
  Humacyte, Inc. (HUMA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
• March 6 ·

  SeekingAlpha
  Humacyte, Inc. (HUMA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
• February 19 ·

  Benzinga
  D. Boral Capital Maintains Buy on Humacyte, Maintains $25 Price Target
• February 18 ·

  Benzinga
  Humacyte Reports Data Evaluating Symvess In Extremity Arterial Trauma Patients
• February 9 ·

  SeekingAlpha
  Humacyte: Positive News For Symvess At Last, But Long-Term Threats Persist

Humacyte Stock Press Releases

Humacyte regularly publishes news on the company's website that are relevant for investors.